Protein kinase and protein phosphatase expression in the central nervous system of G93A mSOD over-expressing mice
Abstract
The expressions of 78 protein kinases, 24 protein phosphatases and 31 phosphoproteins were investigated by Kinetworks™ analysis in brain and spinal cord tissue of transgenic mice over‐expressing G93A mutant superoxide dismutase (mSOD), a murine model of amyotrophic lateral sclerosis (ALS). In the brains of affected mSOD mice, we observed increased expression of cAMP‐dependent protein kinase (PKA, 111% increase compared with control), and protein phosphatase 2B Aα‐catalytic subunit (calcineurin, 109% increase), and reductions in the levels of PAK3 (76% decrease) and protein phosphatase 2C Cβ‐subunit (32% decrease). Increased Ser259 phosphorylation of Raf1 (126% increase) in mSOD mice correlated with higher expression of p73 Raf1 (147% increase). There was also increased p73 Raf1 (69% increase) and Ser259 phosphorylation (45% increase) in the spinal cords of mSOD mice. While adducin underwent enhanced phosphorylation (αS724, 90% increase; γS662, 290% increase) in mSOD brain, its phosphorylation was lower in the mSOD spinal cord (αS724, 53% decrease; γS662, 46% decrease). In spinal cords of affected mSOD mice, we also observed elevated expression of casein kinase 1δ (CK1δ, 157% increase), JAK2 (84% increase), PKA (183% increase), protein kinase C (PKC) δ (123% increase), p124 PKCµ (142% increase), and RhoA kinase (221% increase), and enhanced phosphorylation of extracellular regulated kinases 1 (ERK1, T202/Y204, 90% increase), and 2 (ERK2, T185/Y187, 73% increase), p38 MAP kinase (T180/Y182, 1570% increase), and PKBα (T308, 154% increase; S473, 61% increase). There was also reduced phosphorylation of RB (S780, 45% decrease; S807/S811, 65% decrease), Src (Y418, 63% decrease) and p40 SAPK/JNKβ (T183/Y185, 43% decrease). Variability in the expression of kinases, phosphatases and phosphorylation of their substrates was observed even in mutant animals having a similar phenotype. The expression and phosphorylation differences between mSOD and control mice were dissimilar to those between ALS patients and controls. This finding indicates that the activation of protein kinases and phosphoproteins is different with neuron loss in the mSOD mouse compared with that seen in patients with the sporadic form of ALS.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Activation of the RhoA/ROCK pathway has been implicated in the pathogenesis of ALS, although studied to a lesser degree and focusing on the disease-modifying effects of ROCK inhibition.
“Activation of the RhoA/ROCK pathway has also been implicated in the pathogenesis of ALS, although studied to a lesser degree and focusing on the disease-modifying effects of ROCK inhibition.”
From RhoA Signaling in Neurodegenerative Diseases (2022) · cites this paper as [210]
ROCK expression was increased in sporadic ALS patients.
“ROCK expression was increased in the SOD1G93A transgenic mouse model of ALS and in sporadic ALS patients [210,212].”
From RhoA Signaling in Neurodegenerative Diseases (2022) · cites this paper as [210]
ROCK expression was increased in the SOD1G93A transgenic mouse model of ALS.
“ROCK expression was increased in the SOD1G93A transgenic mouse model of ALS and in sporadic ALS patients [210,212].”
From RhoA Signaling in Neurodegenerative Diseases (2022) · cites this paper as [210]
Cited by
Sorted by citations
RhoA Signaling in Neurodegenerative Diseases
Schmidt, S. I., Blaabjerg, M., Freude, K., & Meyer, M. (2022) · Cells · doi:10.3390/cells11091520 · Cited by 110 · see citing works
Solomon, J. N., Lewis, C. B., Ajami, B., Corbel, S. Y., Rossi, F. M. V., & Krieger, C. (2006) · Glia · doi:10.1002/glia.20331 · Cited by 105 · see citing works
Self-citation
- Authors
- Hu, J. H., Chernoff, K., Pelech, S., & Krieger, C.
- Affiliations
- Simon Fraser University (CA)
- Kinexus Bioinformatics Corporation (Canada) (CA)
- University of British Columbia (CA)
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2003-04
- Volume
- 85
- Issue
- 2
- Pages
- 422-431
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1528604981
- Cited by
- 72
- References
- 0
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 2 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 4 · 2016: 5 · 2015: 1 · 2014: 4 · 2013: 2 · 2012: 4
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Muscular Dystrophy Association
- ALS Society of Canada
- Muscular Dystrophy Canada
- Topics
- Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- protein kinases, protein phosphatase, amyotrophic lateral sclerosis, transgenic mice, protein kinase A, calcineurin, p73, ERK1/2, p38 MAPK, JAK2, Rho kinase
- MeSH terms
- Amyotrophic Lateral Sclerosis, Animals, Brain, Brain Chemistry, Central Nervous System, Disease Models, Animal, Mice, Transgenic, Phosphoprotein Phosphatases, Phosphoproteins, Phosphorylation, Protein Kinases, Spinal Cord, Superoxide Dismutase, Blotting, Western, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review